Literature DB >> 973956

Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.

D J Sumner, A J Russell.   

Abstract

The kinetics of digoxin have been investigated in healthy volunteers using an isotopic tracer technique. A three compartment open kinetic model has been proposed as the simplest model consistent with the plasma, urinary and faecal data obtained. The renal clearance of digoxin (mean +/- s.d.) was found to be 119+/-10 ml/min, which did not differ significantly from the glomerular filtration rate (110+/-14 ml/min). Digoxin extra-renal clearance (mean+/-s.d.) was found to be 47+/-7 ml/min. The model predicts that the tissue concentration attained after four 0.25 mg oral doses spread over 24 h can be achieved within a period of 4 h following a single oral loading dose of 1 mg. Maintenance doses can be derived from a simple formula based on the glomerular filtration rate, extra-renal clearance and bioavailability of the digoxin preparation used.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 973956      PMCID: PMC1428870          DOI: 10.1111/j.1365-2125.1976.tb00596.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

Review 1.  Digitalis (third of four parts).

Authors:  T W Smith; E Haber
Journal:  N Engl J Med       Date:  1973-11-15       Impact factor: 91.245

2.  Letter: Plasma-digoxin concentrations after an intravenous loading dose.

Authors:  A Bertler; B Bergdahl; E Karlsson
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

3.  Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.

Authors:  R H Reuning; R A Sams; R E Notari
Journal:  J Clin Pharmacol New Drugs       Date:  1973-04

4.  Renal tubular secretion of digoxin.

Authors:  E Steiness
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

5.  Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease.

Authors:  C Davidson; D Gibson
Journal:  Br Heart J       Date:  1973-09

6.  Pharmacokinetics of digoxin: interpreting bioavailability.

Authors:  N Sanchez; L B Sheiner; H Halkin; K L Melmon
Journal:  Br Med J       Date:  1973-10-20

7.  An integral approach to the measurement of glomerular filtration rate.

Authors:  A S Malowany; R R Mildenberger; J D Harries; K N Drummond
Journal:  Med Biol Eng       Date:  1973-09

8.  Pharmacokinetics--uses and abuses.

Authors:  P J Fell; M T Stevens
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

9.  Letter: Oral digitalisation.

Authors:  B Whitting; D J Sumner
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

10.  The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H.

Authors:  C E Harrison; R O Brandenburg; P A Ongley; A L Orvis; C A Owen
Journal:  J Lab Clin Med       Date:  1966-05
View more
  27 in total

Review 1.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

2.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

3.  Influence of diet on digoxin dose requirements.

Authors:  J Turner; S M Dobbs; P W Nicholson; A P McGill; E M Rodgers
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

Review 4.  Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy.

Authors:  Roger W Jelliffe
Journal:  Ther Drug Monit       Date:  2012-08       Impact factor: 3.681

Review 5.  Drug interactions with digitalis glycosides.

Authors:  P F Binnion
Journal:  Drugs       Date:  1978-05       Impact factor: 9.546

Review 6.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

8.  Plasma and urinary digoxin in thyroid dysfunction.

Authors:  G M Shenfield; J Thompson; D B Horn
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

9.  Digoxin infusion versus bolus injection in rapid atrial fibrillation: relation between serum level and response.

Authors:  A J Smit; A H Scaf; L H van Essen; K I Lie; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

10.  Pharmacokinetics of digoxin in pregnancy.

Authors:  A M Luxford; G S Kellaway
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.